Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future Directions

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 5, 2009, Pages 502-508

  Tack, Jan ^a   Müller Lissner, Stefan ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; AT 1705; BISACODYL; CISAPRIDE; DOCUSATE CALCIUM; DOCUSATE SODIUM; GUANYLATE CYCLASE ACTIVATOR; ISPAGULA; LACTULOSE; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; MACROGOL; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; METHYLCELLULOSE; NEUROTROPHIN 3; OPIATE ANTAGONIST; OSMOTIC AGENT; PICOSULFATE SODIUM; PLACEBO; POLYCARBOPHIL; PRUCALOPRIDE; RENZAPRIDE; SEROTONIN AGONIST; SODIUM DIHYDROGEN PHOSPHATE; SORBITOL; TD 5108; TEGASEROD; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ANAMNESIS; BARIUM ENEMA; BLOATING; CHRONIC DISEASE; COLONOSCOPY; CONSTIPATION; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FLATULENCE; GASTROESOPHAGEAL REFLUX; HEART INFARCTION; HUMAN; IRRITABLE COLON; NAUSEA; PATIENT SATISFACTION; PHYSICAL EXAMINATION; QUALITY OF LIFE; REVIEW; SIGMOIDOSCOPY; STROKE; SYMPTOMATOLOGY; THROAT IRRITATION; UNSTABLE ANGINA PECTORIS;

CONSTIPATION; HUMANS; INTESTINAL SECRETIONS; LAXATIVES; RECEPTORS, SEROTONIN, 5-HT4;

EID: 67349227863     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.006     Document Type: Review

References (67)

1. Garrigues V., Galvez C., Ortiz V., et al. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 159 (2004) 520-526
2. Lembo A., and Camilleri M. Chronic constipation. N Engl J Med 349 (2003) 1360-1368
3. Pare P., Ferrazzi S., Thompson W., et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 96 (2001) 3130-3137
4. Wald A., Kamm M., Mueller-Lissner S., et al. The BI Omnibus study: an international survey of community prevalence of constipation and laxative use in adults. Gastroenterology 130 Suppl 2 (2006) 508
5. Thompson W.G., and Heaton K.W. Functional bowel disorders in apparently healthy people. Gastroenterology 79 (1980) 283-288
6. Wald A., Scarpignato C., Kamm M.A., et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 26 (2007) 227-236
7. Johanson J., and Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 25 (2007) 599-608
8. Longstreth G., Thompson W., Chey W., et al. Functional bowel disorders. Gastroenterology 130 (2006) 1480-1491
9. Schiller L.R. New and emerging treatment options for chronic constipation. Rev Gastroenterol Disord 4 Suppl 2 (2004) S43-S51
10. Bracco A., and Kahler K. Burden of chronic constipation must include estimates of work productivity and activity impairment in addition to traditional healthcare utilization. Am J Gastroenterol 99 Suppl 10 (2004) S233
11. Irvine E.J., Ferrazzi S., Pare P., et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol 97 (2002) 1986-1993
12. Locke III G., Pemberton J., and Phillips S. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology 119 (2000) 1761-1766
13. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 100 (2005) S1-S4
14. Gonenne J., Esfandyari T., Camilleri M., et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 18 (2006) 911-918
15. Cong P., Pricolo V., Biancani P., et al. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology 133 (2007) 445-453
16. Xiao Z.L., Pricolo V., Biancani P., et al. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology 128 (2005) 667-675
17. Camilleri M., Cowen T., and Koch T.R. Enteric neurodegeneration in ageing. Neurogastroenterol Motil 20 (2008) 185-196
18. Rao S.S., Ozturk R., and Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol 100 (2005) 1605-1615
19. Thompson W., Longstreth G., Drossman D., et al. Functional bowel disorders and functional abdominal pain. Gut 45 (1999) 1143-1147
20. Schiller L., Dennis E., and Toth G. An Internet-based survey of the prevalence and symptom spectrum of chronic constipation. (abstr 723). Am J Gastroenterol 99 Suppl 10 (2004) S234
21. Chinese Society of Gastroenterology C.M.A. Consensus on the guidelines for the diagnosis and treatment of chronic constipation. Chin J Dig Dis 5 (2004) 134-137
22. WGO-OMGE Practice Guideline: Constipation. http://www.omge.org/globalguidelines/guide04/guideline4.htm
23. Chiarioni G., and Whitehead W.E. The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol 5 (2008) 371-382
24. Ramkumar D., and Rao S.S. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 100 (2005) 936-971
25. Tramonte S., Brand M., Mulrow C., et al. The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med 12 (1997) 15-24
26. McRorie J., Daggy B., Morel J., et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 12 (1998) 491-497
27. Petticrew M., Watt I., and Sheldon T. Systematic review of the effectiveness of laxatives in the elderly. Health Technol Assess 1 (1997) 1-52 i-iv
28. Golzarian J., Scott Jr. H., and Richards W. Hypermagnesemia-induced paralytic ileus. Dig Dis Sci 39 (1994) 1138-1142
29. Brandt L., Prather C., Quigley E., et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100 (2005) S5-S22
30. Petticrew M., Rodgers M., and Booth A. Effectiveness of laxatives in adults. Qual Health Care 10 (2001) 268-273
31. Dupont C., Leluyer B., Maamri N., et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 41 (2005) 625-633
32. Lederle F., Busch D., Mattox K., et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med 89 (1990) 597-601
33. Di Palma J., DeRidder P., Orlando R., et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 95 (2000) 446-450
34. Di Palma J., Smith J., and Cleveland M. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol 97 (2002) 1776-1779
35. Di Palma J., Cleveland M., McGowan J., et al. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol 102 (2007) 1964-1971
36. Szojda M.M., Mulder C.J., and Felt-Bersma R.J. Differences in taste between two polyethylene glycol preparations. J Gastrointest Liver Dis 16 (2007) 379-381
37. Migeon-Duballet I., Chabin M., Gautier A., et al. Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population. Curr Med Res Opin 22 (2006) 1227-1235
38. Loening-Baucke V., and Pashankar D. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics 118 (2006) 528-535
39. Dipalma J.A., Cleveland M.V., McGowan J., et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 102 (2007) 1436-1441
40. Bosshard W., Dreher R., Schnegg J., et al. The treatment of chronic constipation in elderly people: an update. Drugs Aging 21 (2004) 911-930
41. Heiny B.M. Langzeitbehandung mit einem pflanzlichen laxitivum. Serumelektroyte und saeurenbasenhaushalt. Arztliche Praxis 28 (1976) 563-564
42. Kienzle-Horn S., Vix J.M., Schuijt C., et al. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin 23 (2007) 691-699
43. Rosprich G. Dauerbehandlung mit laxantien. Therapiewoche 30 (1980) 5836-5837
44. Bengtsson M., and Ohlsson B. Psychological well-being and symptoms in women with chronic constipation treated with sodium picosulphate. Gastroenterol Nurs 28 (2005) 3-12
45. Ruidisch M.H., Hutt H.-J., and König E. Laxanzien-langzeittherapie mit bisacodyl. Wirksamkeit und verträglicheit bei patienten mit rückenmarkverletzungen. Arztliche Forschung 41 (1994) 3-8
46. Muller-Lissner S.A., Kamm M.A., Scarpignato C., et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 100 (2005) 232-242
47. Verne G.N., Davis R.H., Robinson M.E., et al. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 98 (2003) 1112-1116
48. Shaker R., Castell D.O., Schoenfeld P.S., and Spechler S.J. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup Survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 98 (2003) 1112-1116
49. Lang L. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation. Gastroenterology 135 (2008) 6
50. Thomas J., Karver S., Cooney G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358 (2008) 2332-2343
51. Kelleher D., Johanson J., Pobiner B., et al. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist-a study in patients with chronic idiopathic constipation (CIC) not taking opioid medications. (abstr 1239). Am J Gastroenterol 101 (2006) S480
52. Parkman H., Rao S., Reynolds J., et al. Neurotrophin-3 improves functional constipation. Am J Gastroenterol 98 (2003) 1338-1347
53. Johanson J.F., Morton D., Geenen J., et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 103 (2008) 170-177
54. Forte L.R. Guanylin regulatory peptides: structures, biological activities mediated by cyclic gmp and pathobiology. Regul Pept 81 (1999) 25-39
55. Andresen V., Camilleri M., Busciglio I.A., et al. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology 33 (2007) 61-68
56. Tonini M., de Ponti F., di Nucci A., et al. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13 (1999) 1585-1591
57. 4 receptor agonists: similar but not the same. Neurogastroenterol Motil 20 (2008) 99-112
58. Johanson J.F., Wald A., Tougas G., et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2 (2004) 796-805
59. Evans B.W., Clark W.K., Moore D.J., et al. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev 4 (2007) CD003960
60. Briejer M.R., Bosmans J.P., Van Daele P., et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 423 (2001) 71-83
61. Bouras E.P., Camilleri M., Burton D.D., et al. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 44 (1999) 682-686
62. Bouras E.P., Camilleri M., Burton D.D., et al. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology 120 (2001) 354-360
63. Tack J., Van Outryve M., Beyens G., et al. Prucalopride (resolor (R)) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut (2008) [Epub ahead of press]
64. Camilleri M., Kerstens R., Rykx A., et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358 (2008) 2344-2354
65. 4 receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil 19 (2007) 30-38
66. Tack J., Middleton S.J., Horne M.C., et al. Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 23 (2006) 1655-1665
67. Miles C., Fellowes D., Goodman M., et al. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev 4 (2006) CD003448